Human neural stem cells: Phase I started

Neuralstem began an open-label, U.S. Phase I trial to evaluate injectable NSI-566 in 4 patients with thoracic SCI classified as American Spinal Injury Association Impairment Scale (AIS) level A. AIS A is considered to be complete paralysis. ...